|

Intravitreal injection of Faricimab or Aflibercept 2 mg Clinical Trials

1 actively recruiting trial

Also known as: Eylea, Vabysmo

Top Sponsors

  • University Hospital, Alexandroupolis1

Indications

  • Neovascular Age Related Macular Degeneration1
  • Diabetic Macular Edema (DME)1
  • Renal Function Disorder1
  • Diabetes1

Other1 trial

Impact of Intravitreal Faricimab on Renal Function in Diabetic Patients
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.